LAST CO CLOTHING INC
8-K, 2000-07-10
APPAREL, PIECE GOODS & NOTIONS
Previous: LAST CO CLOTHING INC, 10QSB, 2000-07-10
Next: LAST CO CLOTHING INC, 3, 2000-07-10





                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT

     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1933

                         Date of Report:  July 10, 2000

                       Commission File Number:  000-30567


                           Last Company Clothing, Inc.

 Nevada                                                               88-0422308
(Jurisdiction  of  Incorporation)        (I.R.S.  Employer  Identification  No.)

24843  Del  Prado,  Suite  318,  Dana  Point  CA                           92626
(Address of principal executive offices)                              (Zip Code)

Registrant's  telephone  number,  including  area  code:          (949) 248-8933


                ITEM  1.  CHANGE  OF  CONTROL  OF  REGISTRANT.

     On  July  5,  2000,  pursuant to Majority Shareholder Action, the following
proposals  were adopted which result in a change of control of this Corporation.

     (1)  Increase  the  number  of  directors  to  a  maximum  of  15.

     (2)  Approve and empower the Board of Directors to effect, a forward split
of  the  issuer's  common stock, every one share to become two shares, including
the  increase  of  authorized  capital  from  50,000,000  to 100,000,000 shares.

          The record date for entitlement to the forward split is July 20, 2000.
The  date for distribution of the additional one share for every share owned, as
of the close of  business  on  July 20,  2000, shall be July 28, 2000.

     (3)  Ratify  and Approve the acquisition of M-I Vascular Innovations, Inc.,
in  exchange  for  the  issuance  of common shares on a one-to-one basis, not to
exceed  20,000,000  post-split  shares.

     (4)  Approve  and  authorize  a change of the corporate name to become MIVI
Biomedical Technologies, Inc., or similar name at the discretion of the Board of
Directors.

     (5) Elect the following persons as directors to take office upon closing of
acquisition  of  MIVI  Biomedical Technologies, Inc., or similar name: (5.1) Dr.
Robert  Ian  Gordon  Brown,  (5.2)  Dr.  Jean-Francois  Marquis,  (5.3) James D.
Davidson,  (5.4)  Alan  P.  Lindsay,  (5.5)  Zhi-Yong (John) Ma, (5.6) Ronald L.
Handford,  (5.7)  Kita Tosetti, (5.8) Peter K. Jensen, (5.9) Michael Smorch, and
(5.10)  Stephen  Walters.


     ITEM  2.  ACQUISITION  OR  DISPOSITION  OF ASSETS. Please see Item 1 above.


     ITEM  3.  CHANGES  IN  REGISTRANT'S  CERTIFYING  ACCOUNTANT.  None.

                                        1
<PAGE>

     ITEM  4.  BANKRUPTCY  OR  RECEIVERSHIP.  None.


     ITEM  5.  OTHER  EVENTS.  None.


     ITEM  6.  CHANGES OF REGISTRANT'S DIRECTORS. The following persons shall be
and become the Board of Directors of this reorganized corporation to take office
upon  closing  of  acquisition of MIVI Biomedical Technologies, Inc., or similar
name:  (1) Dr. Robert Ian Gordon Brown, (2) Dr. Jean-Francois Marquis, (3) James
D.  Davidson,  (4)  Alan  P.  Lindsay,  (5)  Zhi-Yong  (John)  Ma, (6) Ronald L.
Handford,  (7)  Kita  Tosetti, (8) Peter K. Jensen, (9) Michael Smorch, and (10)
Stephen  Walters.

                                   SIGNATURES

     Pursuant  to  the requirements of the Securities Exchange Act of 1934, this
report  has  been  signed  below  by  the  following  persons  on  behalf of the
Registrant  and  in  the  capacities  and  on  the  date  indicated.

July  10,  2000

                           LAST COMPANY CLOTHING, INC.


                                       by

                               /s/William Stocker
                               ------------------
                                 William Stocker
                           special securities counsel

                                        2
<PAGE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission